Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo
✦ LIBER ✦
Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery
✍ Scribed by D. A. Taberner; Dr L. Poller; J. M. Thomson; G. Lemon; F. J. Weighill
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 328 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Heparin/dihydroergotamine for venous thr
✍
Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. Møller-Larsen; V. E. Knud
📂
Article
📅
1988
🏛
John Wiley and Sons
🌐
English
⚖ 495 KB
👁 1 views
A randomized study of a semisynthetic he
✍
Dr. S. Törngren; K. Kettunen; J. Lahtinen; K. Koppenhagen; P. Brücke; P. Hartl;
📂
Article
📅
1984
🏛
John Wiley and Sons
🌐
English
⚖ 377 KB
👁 2 views
## Abstract The prophylactic effect of a semisynthetic heparin analogue (SSHA) on deep vein thrombosis was investigated in a prospective double-blind multicentre trial. 440 major general surgical and gynaecological patients were randomized to one of three treatment groups: 50 mg SSHA, 37·5 mg SSHA